Thursday, January 27, 2011 2:23:57 PM
Wait till people figure out HOW BIG this product is - crunch some numbers:
Resolution Biomedical, Inc. (RBI) is a privately-held specialty diagnostics company. RBI’s core technology, ClearPrep™, is based on a proprietary formula that dramatically enhances the quality and throughput of diagnostic procedures that require visualization through microscopy, including the 55 million Pap tests, and tens of millions of urine and other cytology tests performed annually in the U.S. In addition, RBI packages, sells and distributes high-quality diagnostic chemistry reagents, and owns exclusive U.S. distribution rights for a line of rapid test kits used to diagnose various animal diseases. ""
Resolution Biomedical, Inc. (RBI) is a privately-held specialty diagnostics company. RBI’s core technology, ClearPrep™, is based on a proprietary formula that dramatically enhances the quality and throughput of diagnostic procedures that require visualization through microscopy, including the 55 million Pap tests, and tens of millions of urine and other cytology tests performed annually in the U.S. In addition, RBI packages, sells and distributes high-quality diagnostic chemistry reagents, and owns exclusive U.S. distribution rights for a line of rapid test kits used to diagnose various animal diseases. ""
Recent VIVKD News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 09:16:08 PM
- Olenox Industries Amends Letter of Intent to Acquire Vivakor's Midstream Business in Oklahoma Stack Play • ACCESS Newswire • 04/10/2026 01:24:00 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 06:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:25:29 PM
